{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:52:07Z","timestamp":1794610327908,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10620-024-08693-2","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:01:42Z","timestamp":1730815302000},"page":"4476-4488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Preventive Measures and Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Individual Patient Data Meta-Analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Christina J.","family":"Sperna Weiland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata S.","family":"Akshintala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmol","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Buxbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badih J.","family":"Elmunzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Fogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Han","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Levenick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan W.","family":"Lua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaffer R. S.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Phillip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Siersema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P. H.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin J. M.","family":"van Geenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"8693_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gie.2023.03.023","volume":"98","author":"VS Akshintala","year":"2023","unstructured":"Akshintala VS, Kanthasamy K, Bhullar FA et al. Incidence, severity, and mortality of post-ERCP pancreatitis: an updated systematic review and meta-analysis of 145 randomized controlled trials. Gastrointest Endosc 2023;98:1\u20136.","journal-title":"Gastrointest Endosc"},{"key":"8693_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1572-0241.2007.01328.x","volume":"102","author":"A Andriulli","year":"2007","unstructured":"Andriulli A, Loperfido S. Efficacy versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis. Official J Am Coll Gastroenterol 2007;102:1539.","journal-title":"Official J Am Coll Gastroenterol"},{"key":"8693_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","volume":"156","author":"AF Peery","year":"2019","unstructured":"Peery AF, Crockett SD, Murphy CC et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology 2019;156:254\u2013272.","journal-title":"Gastroenterology"},{"key":"8693_CR4","unstructured":"Healthcare Cost and Utilization Project 2020. [cited 2020 May 1]; https:\/\/hcupnet.ahrq.gov\/"},{"key":"8693_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/a-1075-4080","volume":"52","author":"JM Dumonceau","year":"2020","unstructured":"Dumonceau JM, Kapral C, Aabakken L et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2020;52:127\u2013149.","journal-title":"Endoscopy"},{"key":"8693_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.gie.2022.09.011","volume":"97","author":"JL Buxbaum","year":"2023","unstructured":"Buxbaum JL, Freeman M, Amateau SK et al. American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence. Gastrointest Endosc 2023;97:163\u2013183.","journal-title":"Gastrointest Endosc"},{"key":"8693_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/MPA.0000000000002090","volume":"51","author":"T Koshitani","year":"2022","unstructured":"Koshitani T, Konaka Y, Ohishi T et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis using temporary pancreatic stents versus rectal nonsteroidal anti-inflammatory drugs: a randomized controlled trial. Pancreas 2022;51:663\u2013670.","journal-title":"Pancreas"},{"key":"8693_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S2468-1253(21)00057-1","volume":"6","author":"CJ Sperna Weiland","year":"2021","unstructured":"Sperna Weiland CJ, Smeets X, Kievit W et al. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial. Lancet Gastroenterol Hepatol 2021;6:350\u2013358.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8693_CR9","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/S0140-6736(16)30310-5","volume":"387","author":"H Luo","year":"2016","unstructured":"Luo H, Zhao L, Leung J et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. Lancet 2016;387:2293\u20132301.","journal-title":"Lancet"},{"key":"8693_CR10","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1007\/s10620-020-06796-0","volume":"66","author":"CJ Sperna Weiland","year":"2021","unstructured":"Sperna Weiland CJ, Engels MML, Poen AC et al. Increased use of prophylactic measures in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. Dig Dis Sci 2021;66:4457\u20134466. https:\/\/doi.org\/10.1007\/s10620-020-06796-0.","journal-title":"Dig Dis Sci"},{"key":"8693_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0163278702025001006","volume":"25","author":"LA Stewart","year":"2002","unstructured":"Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002;25:76\u201397.","journal-title":"Eval Health Prof"},{"key":"8693_CR12","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","volume":"313","author":"LA Stewart","year":"2015","unstructured":"Stewart LA, Clarke M, Rovers M et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. Jama 2015;313:1657\u20131665.","journal-title":"Jama"},{"key":"8693_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001855","volume":"12","author":"JF Tierney","year":"2015","unstructured":"Tierney JF, Vale C, Riley R et al. Individual Participant Data (IPD) meta-analyses of randomised controlled trials: guidance on their use. PLoS Med 2015;12:e1001855.","journal-title":"PLoS Med"},{"key":"8693_CR14","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/01.BRS.0000065484.95996.AF","volume":"28","author":"M van Tulder","year":"2003","unstructured":"van Tulder M, Furlan A, Bombardier C et al. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine 2003;28:1290\u20139.","journal-title":"Spine"},{"key":"8693_CR15","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jclinepi.2011.08.004","volume":"64","author":"SM Chang","year":"2011","unstructured":"Chang SM. The Agency for Healthcare Research and Quality (AHRQ) effective health care (EHC) program methods guide for comparative effectiveness reviews: keeping up-to-date in a rapidly evolving field. J Clin Epidemiol 2011;64:1166\u20131167.","journal-title":"J Clin Epidemiol"},{"key":"8693_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/jrsm.1661","volume":"14","author":"RD Riley","year":"2023","unstructured":"Riley RD, Ensor J, Hattle M et al. Two-stage or not two-stage? That is the question for IPD meta-analysis projects. Res Synth Methods 2023;14:903\u2013910.","journal-title":"Res Synth Methods"},{"key":"8693_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","volume":"62","author":"PA Banks","year":"2013","unstructured":"Banks PA, Bollen TL, Dervenis C et al. Classification of acute pancreatitis\u20132012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102\u2013111.","journal-title":"Gut"},{"key":"8693_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S2468-1253(21)00170-9","volume":"6","author":"VS Akshintala","year":"2021","unstructured":"Akshintala VS, Sperna Weiland CJ, Bhullar FA et al. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2021;6:733\u2013742.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8693_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj 2011;343:d5928.","journal-title":"Bmj"},{"key":"8693_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"8693_CR21","unstructured":"Ryan R. Cochrane Consumers and Communication Review Group. \u2018Heterogeneity and subgroup analyses in Cochrane Consumers and Communication Group reviews: planning the analysis at protocol stage. http:\/\/cccrg.cochrane.org, December 2016 (accessed DATE). [cited December 2016 December 2016]; http:\/\/cccrg.cochrane.org"},{"key":"8693_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cgh.2013.07.026","volume":"12","author":"J Buxbaum","year":"2014","unstructured":"Buxbaum J, Yan A, Yeh K et al. Aggressive hydration with lactated Ringer\u2019s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 2014;12:303\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8693_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cgh.2016.06.007","volume":"15","author":"JH Choi","year":"2017","unstructured":"Choi JH, Kim HJ, Lee BU et al. Vigorous periprocedural hydration with lactated ringer\u2019s solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients. Clin Gastroenterol Hepatol 2017;15:86\u201392.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8693_CR24","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","volume":"366","author":"BJ Elmunzer","year":"2012","unstructured":"Elmunzer BJ, Scheiman JM, Lehman GA et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med 2012;366:1414\u20131422.","journal-title":"N Engl J Med"},{"key":"8693_CR25","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1053\/j.gastro.2015.12.040","volume":"150","author":"JM Levenick","year":"2016","unstructured":"Levenick JM, Gordon SR, Fadden LL et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients. Gastroenterology 2016;150:911\u20137 (quiz e19).","journal-title":"Gastroenterology"},{"key":"8693_CR26","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1007\/s10620-015-3609-9","volume":"60","author":"GW Lua","year":"2015","unstructured":"Lua GW, Muthukaruppan R, Menon J. Can rectal diclofenac prevent post endoscopic retrograde cholangiopancreatography pancreatitis? Dig Dis Sci 2015;60:3118\u201323. https:\/\/doi.org\/10.1007\/s10620-015-3609-9.","journal-title":"Dig Dis Sci"},{"key":"8693_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.gie.2016.10.033","volume":"85","author":"SRS Mok","year":"2017","unstructured":"Mok SRS, Ho HC, Shah P et al. Lactated Ringer\u2019s solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. Gastrointest Endosc 2017;85:1005\u20131013.","journal-title":"Gastrointest Endosc"},{"key":"8693_CR28","doi-asserted-by":"publisher","first-page":"E860","DOI":"10.1055\/a-0886-6384","volume":"7","author":"V Phillip","year":"2019","unstructured":"Phillip V, Pukitis A, Epstein A et al. Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial. Endosc Int Open 2019;7:E860\u2013E868.","journal-title":"Endosc Int Open"},{"key":"8693_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015742","volume":"98","author":"JH Lai","year":"2019","unstructured":"Lai JH, Hung CY, Chu CH et al. A randomized trial comparing the efficacy of single-dose and double-dose administration of rectal indomethacin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. Medicine 2019;98:e15742.","journal-title":"Medicine"},{"key":"8693_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S2468-1253(19)30337-1","volume":"5","author":"EL Fogel","year":"2020","unstructured":"Fogel EL, Lehman GA, Tarnasky P et al. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial. Lancet Gastroenterol Hepatol 2020;5:132\u2013141.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8693_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/den.12908","volume":"29","author":"BJ Elmunzer","year":"2017","unstructured":"Elmunzer BJ. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis. Dig Endosc 2017;29:749\u2013757.","journal-title":"Dig Endosc"},{"key":"8693_CR32","doi-asserted-by":"publisher","first-page":"16658","DOI":"10.1038\/s41598-021-96142-9","volume":"11","author":"J Canena","year":"2021","unstructured":"Canena J, Lopes L, Fernandes J et al. Efficacy and safety of primary, early and late needle-knife fistulotomy for biliary access. Sci Rep 2021;11:16658.","journal-title":"Sci Rep"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08693-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08693-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T07:27:57Z","timestamp":1740209277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08693-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["8693"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08693-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JPHD has received research funding from Gilead and Abbvie. EJMvG has received research funding from Boston Scientific, Micro-Tech, Pentax, Tae Woong, Olympus, Viatris, and Zambon Medical and served as a consultant for MTW-Endoskopie. PS has received research funding from Pentax, Boston Scientific, Micro-Tech, and The Enose Company. VK reports personal fees from Abbvie, is an advisory board participant for Cook Medical, and receives grants from Orgensis and Theraly. VSA is co-founder and chief medical officer of Origin Endoscopy Inc., Solv Endotherapy Inc. and consultant for Olympus and has received educational grants from Boston Scientific, Medtronic, Abbvie, and Chirhoclin. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"PROSPERO: registration number CRD42021231197.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration no. of study"}},{"value":"N\/A.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}]}}